These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10901032)

  • 1. [Prognosis markers and therapeutic approach in rheumatoid arthritis].
    Figueroa Pedrosa MM; González Beneitez C; Belzunegui Otano J
    Rev Clin Esp; 2000 May; 200 Monog 1():87-95. PubMed ID: 10901032
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognosis of rheumatoid arthritis].
    Möttönen T
    Duodecim; 1996; 112(24):2337-8. PubMed ID: 10605235
    [No Abstract]   [Full Text] [Related]  

  • 3. [Early diagnosis and therapy of rheumatoid arthritis. Discussion].
    Nihon Naika Gakkai Zasshi; 1994 Nov; 83(11):1954-71. PubMed ID: 7852803
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.
    van Venrooij WJ; Hazes JM; Visser H
    Neth J Med; 2002 Nov; 60(10):383-8. PubMed ID: 12607587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atypical variants in the course of rheumatic arthritis].
    Erov NK
    Ter Arkh; 1993; 65(5):30-4. PubMed ID: 8036592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A model for assessing the effectiveness of the health resort treatment of rheumatoid arthritis patients].
    Knopf D
    Vopr Kurortol Fizioter Lech Fiz Kult; 1986; (4):33-6. PubMed ID: 3765469
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 10. How to predict prognosis in early rheumatoid arthritis.
    Morel J; Combe B
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):137-46. PubMed ID: 15588975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of early rheumatoid arthritis.
    Brown AN
    J S C Med Assoc; 2003 Oct; 99(10):296-302. PubMed ID: 14621660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biologicals in early rheumatoid arthritis.
    Haque UJ; Bathon JM
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):179-89. PubMed ID: 15588978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Altered T-cells against rheumatoid arthritis. Markers as tools for early prognosis].
    Orn P
    Lakartidningen; 1996 Feb; 93(7):570-3. PubMed ID: 8642917
    [No Abstract]   [Full Text] [Related]  

  • 14. What have we learnt from early rheumatoid arthritis cohorts?
    Young A
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):3-12. PubMed ID: 19233041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Future trends in the treatment and diagnosis of rheumatoid arthritis].
    Matsui N
    Ryumachi; 2000 Oct; 40(5):795-7. PubMed ID: 11215157
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rheumatoid polyarthritis].
    le Goff P
    Soins; 1986 Mar; (473):19-23. PubMed ID: 3637012
    [No Abstract]   [Full Text] [Related]  

  • 17. The continuing challenge of predictive factors in rheumatoid arthritis.
    Coste J; Paolaggi JB
    J Rheumatol; 1997 Aug; 24(8):1653-4. PubMed ID: 9263168
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of prognostic markets to guide biologic therapies for rheumatoid arthritis.
    D'Arcy CA; Willkens RF
    J Rheumatol; 2002 Dec; 29(12):2662; author reply 2662-3. PubMed ID: 12465172
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic and prognostic criteria most useful in the assessment of various therapeutic methods in early rheumatoid arthritis in adults].
    Wawrzyńska-Pagowska J; Brzezińska B; Graff-Wroblewska T; Juszczyk T; Michalski J; Pakula A; Piotrowska D; Wójcik-Scislowska M
    Reumatologia; 1974; 12(3):221-8. PubMed ID: 4409206
    [No Abstract]   [Full Text] [Related]  

  • 20. [The choice of the regimen for therapeutic plasmapheresis].
    Movshev BE; Kalinin NN; Petrova VI
    Ter Arkh; 1992; 64(9):90-3. PubMed ID: 1481166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.